Patient mobility across the EU: issues and challenges

Frayling TM, Evans JC, Bulman MP, et aL Beta-cell genes and diabetes: molecular and clinical characteriza-tion of mutations in transcription factors. Diabetes 2001; 50(Suppl 1): S94—S100.

Shepherd M, Sparkes AC, Hattersley AT. Genetic testing in maturity onset diabetes of the young (MODY); a new challenge for the diabetic clinic. Pract Diabetes Int 2001; 18: 16–21.

Pearson ER, Starkey BJ, Powell RJ, et aL Genetic aetiology of hypergly-caemia determines response to treat-ment in diabetes. Lancet 2003; 362(9392): 1275–1281.

Owen K, Hattersley AT. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract Res Clin Endocrinol Metab 2001; 15(3): 309–323.

Lambert AP, Ellard S, Allen LI, et aL Identifying hepatic nuclear factor 1 alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes. Diabetes Care 2003; 26(2): 333–337.

Shepherd MH, Hattersley AT, Ellard S. Integrating genetics into diabetes care: a new role for DSNs. J Nursing 2003; 7(8): 289–292.

Gloyn AL. Glucokinase (GCK) muta-tions in hyper- and hypoglycemia: Maturity-onset diabetes of the young, permanent neonatal dia-betes, and hyperinsulinemia of infancy. Hum Mutat 2003; 22(5): 353–362.